Describe the treatment approach.
Most cases of IgAV are self-limiting and only require supportive care (e.g., pain management) with regular outpatient follow-up. Severe IgAV requires hospitalization and intensive medical therapy.
Describe the treatment of mild disease.
Outpatient treatment
Usually no treatment necessary
NSAIDs for pain management, rest, and adequate hydration
Discontinuation of suspected precipitating drug, if applicable
Describe the treatment of severe disease.
Inpatient treatment
Systemic glucocorticoids for severe abdominal pain not relieved by NSAIDs
IV fluids to maintain hydration
In case of severe renal disease
IV methylprednisolone pulse therapy [8]
Renal transplantation in end-stage renal disease (ESRD)
Acute dialysis in the case of acute kidney injury (AKI)
Consider antihypertensive agents if hypertension is present.
Reduce salt intake
List complications.
Renal
In some cases, IgAV nephritis may progress to nephrotic syndrome.
Serious complication: rapid-progressive glomerulonephritis (RPGN) with crescent formation
Gastrointestinal
Intussusception
Small bowel infarction or perforation
Describe the follow-up.
All patients
Blood pressure monitoring and urinalysis
Timing
Symptomatic patients: weekly or biweekly testing
After symptoms subside: monthly testing for the first 6 months, then every other month for an additional 6 months
Symptom-free for > 12 months: perform tests at subsequent well-child visits
In patients with abnormal blood pressure or urinalysis
Measure serum creatinine
Referral to a pediatric nephrologist if serum creatinine levels are abnorm
Describe the prognosis.
Usually resolves with full recovery, however, relapse is likely in patients with previous renal involvement.
The prognosis is worse in patients with nephrotic range proteinuria. In rare cases (∼ 1%), ESRD may occur.
Zuletzt geändertvor 2 Jahren